Radiofrequency microneedling has become one of the more crowded device categories in aesthetics, and Morpheus8 has been the name most associated with it. Our census of 48,198 verified US aesthetic practices lets us see exactly where that footprint sits, and where it does not.
The national count
Morpheus8 appears in roughly 1,815 practice menus nationally, against a broader microneedling category (including non-RF variants) of 6,248 mentions. That gap, 1,815 out of 6,248, is the size of the conversion opportunity for any RF microneedling competitor: most practices advertising microneedling in some form have not yet standardized on an RF device.
Where it concentrates
By state, Morpheus8 mentions cluster where you would expect the broader device market to cluster, but not proportionally:
| State | Morpheus8 mentions |
|---|---|
| California | 246 |
| Florida | 215 |
| Texas | 166 |
| New York | 74 |
| Colorado | 67 |
California and Florida together account for roughly a quarter of national Morpheus8 mentions. Texas, despite having a larger overall practice count than Florida in our census, sits meaningfully behind both, which suggests device-specific saturation does not track general practice density.
Colorado's appearance in the top five, ahead of much larger states by practice count, lines up with the state's above-average density of aesthetic practices per capita generally. Colorado ranks second nationally in aesthetic practices per million residents, at 121, behind only Arizona's 141. A dense, well-capitalized aesthetic market tends to adopt name-brand RF devices earlier.
Reading the gap between states
New York's 74 mentions look low next to its overall practice count of 1,130 statewide, the fourth-highest in the country. That gap between overall practice density and a specific device's footprint is exactly the kind of signal a territory plan should be built around: New York is not a market where RF microneedling adoption has caught up to the size of the practice base, which makes it a market worth a harder look for a competitive RF device rather than a market to assume is already saturated.
What this means for a rep or manufacturer
A competitive RF microneedling device does not need to convert Morpheus8 loyalists everywhere at once. The better play is the 4,433 practices nationally advertising some form of microneedling without the RF component, or without a named RF brand at all. Those practices have already signaled interest in the treatment category. They have not yet been sold on which device delivers it.
The state-level concentration also matters for territory prioritization. A rep working Texas or New York is competing against Morpheus8 in fewer accounts, proportionally, than a rep working California or Florida, which changes both the pitch and the timeline.
Want this cut for your territory? Book a demo.